$9.24
0.252.78%
Last update: Oct 30, 4:48 PM
ORIC Pharmaceuticals Inc (ORIC) Stock Price, Quote, News & History
ORICNASDAQ
Analysts raised targets for ACI, ORIC, JPM, SHOP, META and U; KTB upgraded to Buy. Domino’s target was cut.
You can purchase shares of ORIC Pharmaceuticals (NASDAQ:ORIC) through any online brokerage.
Other companies in ORIC Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
ORIC Pharmaceuticals has a consensus price target of $20.42.
The stock price for ORIC Pharmaceuticals (NASDAQ: ORIC) is $9.42 last updated October 30, 2026 at 4:48 PM EDT.
There are no upcoming dividends for ORIC Pharmaceuticals.
ORIC Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for ORIC Pharmaceuticals.
ORIC Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision...
